Lina Yang

Dr. Lina Yang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2023 in Apoptosis
Verified
Journal Article
Closed access
GCGuang Chen
Guang Chen
HZHuhu Zhang
Huhu Zhang
HSHongxiao Sun
Hongxiao Sun
XDXiaoyan Ding
Xiaoyan Ding
GLGuoxiang Liu
Guoxiang Liu
LYLina Yang
Lina Yang

Verified
Journal Article
Open access
PDF file
YLYa Li
Ya Li
HZHuhu Zhang
Huhu Zhang
CYChunjuan Yu
Chunjuan Yu
XDXiaolei Dong
Xiaolei Dong
FYFanghao Yang
Fanghao Yang
LYLina Yang
Lina Yang
Mitochondria are a unique type of semi-autonomous organelle within the cell that carry out essential functions crucial for the cell’s survival and well-being. They are the location where eukaryotic cells carry out energy metabolism. Aside from producing the majority of ATP through oxidative phosphorylation, which provides essential energy for cellular functions, mitochondria also participate in other metabolic processes within the cell, such as the electron transport chain, citric acid cycle, and β-oxidation of fatty acids. Furthermore, mitochondria regulate the production and elimination of ROS, the synthesis of nucleotides and amino acids, the balance of calcium ions, and the process of cell death. Therefore, it is widely accepted that mitochondrial dysfunction is a factor that causes or contributes to the development and advancement of various diseases. These include common systemic diseases, such as aging, diabetes, Parkinson’s disease, and cancer, as well as rare metabolic disorders, like Kearns–Sayre syndrome, Leigh disease, and mitochondrial myopathy. This overview outlines the various mechanisms by which mitochondria are involved in numerous illnesses and cellular physiological activities. Additionally, it provides new discoveries regarding the involvement of mitochondria in both disorders and the maintenance of good health.

22 April 2024 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
HZHuhu Zhang
Huhu Zhang
QSQinghang Song
Qinghang Song
KSKaiwen Shang
Kaiwen Shang
YLYa Li
Ya Li
LJLiangqian Jiang
Liangqian Jiang
LYLina Yang
Lina Yang
The Tetraspanins (Tspan) protein family, also known as the tetraspanin family, contains 33 family members that interact with other protein molecules such as integrins, adhesion molecules, and T cell receptors by forming dimers or heterodimers. The Tspan protein family regulates cell proliferation, cell cycle, invasion, migration, apoptosis, autophagy, tissue differentiation, and immune response. More and more studies have shown that Tspan proteins are involved in tumorigenesis, epithelial-mesenchymal transition, thrombosis, tumor stem cell, and exosome signaling. Some drugs and microRNAs can inhibit Tspan proteins, thus providing new strategies for tumor therapy. An in-depth understanding of the functions and regulatory mechanisms of the Tspan protein family, which can promote or inhibit tumor development, will provide new strategies for targeted interventions in the future.

11 December 2023 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
HZHuhu Zhang
Huhu Zhang
XDXiaolei Dong
Xiaolei Dong
XDXiaoyan Ding
Xiaoyan Ding
GLGuoxiang Liu
Guoxiang Liu
FYFanghao Yang
Fanghao Yang
LYLina Yang
Lina Yang
Background: Intrahepatic cholangiocarcinoma (ICC) accounts for about 15% of primary liver cancer, and the incidence rate has been rising in recent years. Surgical resection is the best treatment for ICC, but the 5-year survival rate is less than 30%. ICC signature genes are crucial for the early diagnosis of ICC, so it is especially important to find its signature genes and therapeutic drug. Here, we studied that bufalin targeting CAMKK2 promotes mitochondrial dysfunction and inhibits the occurrence and metastasis of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway. Methods: IC50 of bufalin in ICC cells was determined by CCK8 and invasive and migratory abilities were verified by wound healing, cell cloning, transwell and Western blot. IF and IHC verified the expression of CAMKK2 between ICC patients and normal subjects. BLI and pull-down demonstrated the binding ability of bufalin and CAMKK2. Bioinformatics predicted whether CAMKK2 was related to the Wnt/β-catenin pathway. SKL2001, an activator of β-catenin, verified whether bufalin acted through this pathway. In vitro and in vivo experiments verified whether overexpression of CAMKK2 affects the proliferative and migratory effects of ICC. Transmission electron microscopy verified mitochondrial integrity. Associated Ca2+ levels verified the biological effects of ANXA2 on ICC. Results: It was found that bufalin inhibited the proliferation and migration of ICC, and CAMKK2 was highly expressed in ICC, and its high expression was positively correlated with poor prognosis.CAMKK2 is a direct target of bufalin, and is associated with the Wnt/β-catenin signaling pathway, which was dose-dependently decreased after bufalin treatment. In vitro and in vivo experiments verified that CAMKK2 overexpression promoted ICC proliferation and migration, and bufalin reversed this effect. CAMKK2 was associated with Ca2+, and changes in Ca2+ content induced changes in the protein content of ANXA2, which was dose-dependently decreasing in cytoplasmic ANXA2 and dose-dependently increasing in mitochondrial ANXA2 after bufalin treatment. In CAMKK2 overexpressing cells, ANXA2 was knocked down, and we found that reversal of CAMKK2 overexpression-induced enhancement of ICC proliferation and migration after siANXA2. Conclusions: Our results suggest that bufalin targeting CAMKK2 promotes mitochondrial dysfunction and inhibits the proliferation and migration of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway. Thus, bufalin, as a drug, may also be used for cancer therapy in ICC in the future.

17 September 2024 in Biomarker Research
Verified
Journal Article
Open access
PDF file
HZHuhu Zhang
Huhu Zhang
FSFulin Sun
Fulin Sun
SJShuyao Jiang
Shuyao Jiang
FYFanghao Yang
Fanghao Yang
XDXiaolei Dong
Xiaolei Dong
BLBing Li
Bing Li
Methyltransferase-like protein is a ubiquitous enzyme-like protein in the human body, with binding domains for nucleic acids, proteins and other small molecules, and plays an important role in a variety of biological behaviours in normal organisms and diseases, characterised by the presence of a methyltransferase-like structural domain and a structurally conserved SAM-binding domain formed by the seven-stranded β-fold structure in the center of the protein. With the deepening of research, the METTL protein family has been found to be abnormally expressed in a variety of tumor diseases, and the clarification of its relationship with tumor diseases can be used as a molecular therapeutic target and has an important role in the prognosis of tumors. In this paper, we review the structure, biological process, immunotherapy, drug-targeted therapy, and markers of the METTL protein family to provide new ideas for the diagnosis and treatment of tumors.

3 November 2025 in Advanced Science
Verified
Journal Article
Open access
QSQinghang Song
Qinghang Song
YYYuxuan Yang
Yuxuan Yang
LYLina Yang
Lina Yang
Regulated cell death is fundamental to cellular homeostasis, with metal‐dependent pathways emerging as critical mechanisms influencing cell fate decisions. This comprehensive review examines the emerging landscape of metal‐dependent regulated cell death pathways, focusing on ferroptosis, cuproptosis, and the hypothetical concept of “cobaltosis.” Ferroptosis, characterized by iron‐catalyzed lipid peroxidation and glutathione depletion, has emerged as a critical pathway in cancer, neurodegeneration, and ischemia‐reperfusion injury. Cuproptosis, a recently defined copper‐induced death mechanism, operates through direct binding of copper to lipoylated mitochondrial proteins, causing proteotoxic stress and metabolic collapse. Evidence for cobaltosis is critically evaluated as a potential distinct regulated cell death pathway, cobalt's known cellular impacts are examined, and a rigorous experimental framework is proposed for its investigation and validation as a distinct entity. This review comparatively analyzes the core mechanisms, highlighting the distinct roles of reactive oxygen species and mitochondria in each pathway. The intricate crosstalk and divergence among these death modalities are explored, introducing the concept of a “metal death code” that dictates the cellular fate in response to specific metal stresses. Furthermore, advanced technologies for detecting and dissecting these pathways are discussed, and their significant translational potential for treating diseases characterized by metal dyshomeostasis is considered, such as cancer and neurodegeneration.